These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12775494)

  • 1. Genomics and the search for novel biomarkers in toxicology.
    Tugwood JD; Hollins LE; Cockerill MJ
    Biomarkers; 2003; 8(2):79-92. PubMed ID: 12775494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA; Yang Y; Waring JF
    Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of transcriptome analysis in pre-clinical toxicology.
    Searfoss GH; Ryan TP; Jolly RA
    Curr Mol Med; 2005 Feb; 5(1):53-64. PubMed ID: 15720270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
    Merrick BA; Bruno ME
    Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans?
    Zhang M; Chen M; Tong W
    Chem Res Toxicol; 2012 Jan; 25(1):122-9. PubMed ID: 22122743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic-based biomarkers of drug-induced nephrotoxicity.
    Davis JW; Kramer JA
    Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):95-101. PubMed ID: 16863471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicogenomics in drug development.
    Guerreiro N; Staedtler F; Grenet O; Kehren J; Chibout SD
    Toxicol Pathol; 2003; 31(5):471-9. PubMed ID: 14692614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State-of-the-art genomics approaches in toxicology.
    Van Hummelen P; Sasaki J
    Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and measurement of genomic biomarkers of nephrotoxicity.
    Goodsaid FM
    J Pharmacol Toxicol Methods; 2004; 49(3):183-6. PubMed ID: 15172014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data.
    Irwin RD; Boorman GA; Cunningham ML; Heinloth AN; Malarkey DE; Paules RS
    Toxicol Pathol; 2004; 32 Suppl 1():72-83. PubMed ID: 15209406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of genomics in model in vitro systems.
    Casciano DA
    Adv Exp Med Biol; 2012; 745():210-20. PubMed ID: 22437820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems toxicology used in nanotoxicology: mechanistic insights into the hepatotoxicity of nano-copper particles from toxicogenomics.
    Yang B; Wang Q; Lei R; Wu C; Shi C; Wang Q; Yuan Y; Wang Y; Luo Y; Hu Z; Ma H; Liao M
    J Nanosci Nanotechnol; 2010 Dec; 10(12):8527-37. PubMed ID: 21121362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicogenomics in biomarker discovery.
    Decristofaro MF; Daniels KK
    Methods Mol Biol; 2008; 460():185-94. PubMed ID: 18449488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Japanese toxicogenomics project: application of toxicogenomics.
    Uehara T; Ono A; Maruyama T; Kato I; Yamada H; Ohno Y; Urushidani T
    Mol Nutr Food Res; 2010 Feb; 54(2):218-27. PubMed ID: 20041446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The introduction of toxicogenomics; potential new markers of hepatotoxicity.
    Heijne WH; Stierum RH; Leeman WR; van Ommen B
    Cancer Biomark; 2005; 1(1):41-57. PubMed ID: 17192031
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicogenomics in predictive toxicology in drug development.
    Suter L; Babiss LE; Wheeldon EB
    Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicogenomics in drug discovery: from preclinical studies to clinical trials.
    Yang Y; Blomme EA; Waring JF
    Chem Biol Interact; 2004 Nov; 150(1):71-85. PubMed ID: 15522262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
    Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
    Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.